754 related articles for article (PubMed ID: 27150044)
1. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
2. Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
Somsak V; Uthaipibull C; Prommana P; Srichairatanakool S; Yuthavong Y; Kamchonwongpaisan S
Malar J; 2011 Oct; 10():291. PubMed ID: 21981896
[TBL] [Abstract][Full Text] [Related]
3. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites.
Hyde JE
Pharmacol Ther; 1990; 48(1):45-59. PubMed ID: 2274577
[TBL] [Abstract][Full Text] [Related]
4. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
Nirmalan N; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
[TBL] [Abstract][Full Text] [Related]
5. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
[TBL] [Abstract][Full Text] [Related]
7. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
Malar J; 2011 May; 10():119. PubMed ID: 21554743
[TBL] [Abstract][Full Text] [Related]
8. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
9. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites.
Fohl LM; Roos DS
Mol Microbiol; 2003 Nov; 50(4):1319-27. PubMed ID: 14622418
[TBL] [Abstract][Full Text] [Related]
10. Inducible knockdown of Plasmodium gene expression using the glmS ribozyme.
Prommana P; Uthaipibull C; Wongsombat C; Kamchonwongpaisan S; Yuthavong Y; Knuepfer E; Holder AA; Shaw PJ
PLoS One; 2013; 8(8):e73783. PubMed ID: 24023691
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials.
Brobey RK; Sano G; Itoh F; Aso K; Kimura M; Mitamura T; Horii T
Mol Biochem Parasitol; 1996 Oct; 81(2):225-37. PubMed ID: 8898337
[TBL] [Abstract][Full Text] [Related]
12. Divergent regulation of dihydrofolate reductase between malaria parasite and human host.
Zhang K; Rathod PK
Science; 2002 Apr; 296(5567):545-7. PubMed ID: 11964483
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Plasmodium knowlesi dihydrofolate reductase-thymidylate synthase and sensitivity to antifolates.
Ittarat W; Pornthanakasem W; Mungthin M; Suwandittakul N; Leelayoova S; Tarnchompoo B; Yuthavong Y; Kongkasuriyachai D; Leartsakulpanich U
Parasitol Int; 2018 Dec; 67(6):787-792. PubMed ID: 30114522
[TBL] [Abstract][Full Text] [Related]
14. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.
Wu Y; Kirkman LA; Wellems TE
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1130-4. PubMed ID: 8577727
[TBL] [Abstract][Full Text] [Related]
15. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
Wooden JM; Hartwell LH; Vasquez B; Sibley CH
Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
[TBL] [Abstract][Full Text] [Related]
16. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial target vulnerability of the putative
Leela N; Prommana P; Kamchonwongpaisan S; Taechalertpaisarn T; Shaw PJ
PeerJ; 2024; 12():e16595. PubMed ID: 38239295
[TBL] [Abstract][Full Text] [Related]
18. Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum.
Wang P; Nirmalan N; Wang Q; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 May; 135(1):77-87. PubMed ID: 15287589
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial effect of cell penetrating peptides derived from the junctional region of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
Chaianantakul N; Sungkapong T; Supatip J; Kingsang P; Kamlaithong S; Suwanakitti N
Peptides; 2020 Sep; 131():170372. PubMed ID: 32673701
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient.
Zindrou S; Nguyen PD; Nguyen DS; Sköld O; Swedberg G
Exp Parasitol; 1996 Oct; 84(1):56-64. PubMed ID: 8888732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
